Kufunganya Kurapa uye BuSpar
BuSpar (buspirone hydrochloride) inoshandiswa kurapa zvinetso zvekuzvidya mwoyo uye kwekusunungurwa kwenguva pfupi kubva mukuzvidya mwoyo. BuSpar haisati yakabatana nemakemikari kana pharmacologically kune mamwe mishonga inopesana nezvinodhaka zvakadai se benzodiazepines kana zvimwe zvinoshandiswa. Kubudirira kweBuPpar mukurapa chirwere chinokonzera kushungurudzika kwepfungwa (GAD) kwatangwa.
Bristol-Meyers Squibb akawana kugamuchirwa kubva kuDain and Drug Administration (FDA) muna 1986 kuitira kushandiswa kwebhasipirone (zita rebhizimisi rinonzi BuSpar) rinoshandiswa mukurapa GAD.
Zvisinei, iyo patent yakapera muna 2001 uye buspirone ikozvino yatengeswa sechirwere chinowanzoitika.
Method of Action
Buspirone inobva kumudzidza weAzaspirone wemishonga uye inoguma pamusana pekutengesa kwe serotonin uye noradrenergic uye dopaminergic.
Nzira Yokutora BuSpar
Mahwendefa eBupar anofanirwa kutorwa nguva dzose pamwe nekudya kana kunze. Inowanzotorwa kaviri kana katatu zuva nezuva.
Nhungamiro yeDosage
Iko rinotaurirwa kutanga chirwere cheBupar is 5 mg kaviri zuva rimwe nerimwe. Izvozvo zvinogona kuwedzerwa ne 5 mg kwemazuva maviri kusvika ku3, uye nepamusoro peji inenge isingadariki 60 mg.
Ndiani Haafaniri Kutora BuSpar
Buspar (buspirone hydrochloride) haafaniri kutorwa neavo vane tsitsi kune zvinodhaka, uye inofanira kushandiswa nekuchenjerera pamberi pechinhu chakakanganiswa nechiropa kana kuti yehutano huripo hwehutano.
Mishonga Inopindirana
BuSpar inogona kuwirirana nemishonga yakawanda inosanganisira monoamine oxidase inhibitors (MAOIs) .
Zvakakosha kuti chiremba wako anoziva mishonga yose yauri kutora ikozvino. Mukuwedzera, zvakanakisisa kudzivisa kushandisa doro paunotora BuSpar.
Migumisiro yakaipa
Mhando yakawanda yemigumisiro yakaipa inogona kuitika pakutora Buspar, iyo inowanzova chizivi, chiyeuchi, musoro, kutya kana kufara, uye kuchena.
Zvimwe zvinogona kukanganisa zvinosanganisira zvinotevera:
- kugona, kuneta
- kurutsa, kutsamwisa mudumbu, kurwadziwa kwepamu
- kuvhiringidza, chirwere
- dry mouth
- kunetseka kurara
- kushaya simba, kupera
Associated Risks
Kunyange zvazvo BuSpar isingasviki kudarika mishonga yakawanda yakawanda inoshungurudza, shandisa kungwarira kana iwe uchifambisa, unoshandisa mishonga kana kuti uchiitawo mabasa ane ngozi. Kune ngozi shomanana yekuchengetedza muviri kana kwepfungwa kuBupar, uye ngozi yekuwedzeresa yakazara.
BuSpar uye Social Social Anxiety Disorder
Chimwe chidzidzo chiduku kubva muna 1993 chakaratidza kuvandudzwa mushure mekushandiswa kwebhapirone mumasvondo gumi nemaviri akazarurirwa nevarwere 17 vane huwandu hwezvemagariro evanhu vanotsvaga chirongwa che DSM-III-R (12 varwere vakaratidza kuvandudza). Zvisinei, kaviri-blind blind-controlled controlled study of 30 patient with SAD muna 1997 yakaratidza kusava nekuvandudzwa kwakaenzaniswa ne placebo.
Izvi zvinoratidza kuti buspirone sechinhu chisarudzo chisina kukodzera chinogona kunge chisingabatsiri chinetso chevanhu chinokonzera kushushikana chisingaendi pamwe nezvimwe zvirwere. Zvisinei, kana iwe usingapinduri kune mamwe mishonga sekusarudza serotonin reuptake inhibitors (SSRIs), buspirone inogona kunge iri sarudzo yekuwedzera chirongwa chenyu chekurapa ikozvino.
Sources:
Halaby A, Haddad RS, Naja WJ. Kwete-Anodzvinyirira Kurapa Kwemagariro Evanhu Kuzvidya Mwoyo Dambudziko: Kudzokorora. Curr Clin Pharmacol . February 2013.
Schneier FR, Saoud JB, Campeas R, et al. Buspirone mumagariro evanhu. J Clin Psychopharmacol . 1993; 13 (4): 251-256.
US National Library of Medicine. Buspirone. Yakasvika musi waMay 24, 2016.
van Vliet IM, den Boer JA, Westenberg HG, Pian KL. Mishonga yemigumisiro yebuspirone munzanga yepamusoro phobia: chidzidzo cheviri-blind blind-controlled controlled. J Clin Psychiatry . 1997; 58 (4): 164-168.